Extensive experience in Clinical Trials in Ophthalmology

Extensive experience, trained staff and an excellent knowledge of the pharmaceutical industry coupled with a unique expertise clinical trials in ophthalmology are the key to anticipate the risks, drive the trials to completion efficiently and insure your success.

Iris Pharma has built a privileged and well-established relationship with leading professors in clinical trials in ophthalmology, academic centers and investigators in order to take the best start in choosing the best route for your study.

Clinical Trials in Ophthalmology Specialists

With a strong knowledge of regulatory guidelines, Iris Pharma will ensure the overall operational conduct of clinical trials in ophthalmology (phase 1, phase 2, phase 3 and phase 4) according to the current Good Clinical Practice.

An Expert in Clinical Trials in Ophthalmology

Iris Pharma has announced the completion of its merger with Clirophtha, a unique clinical research organization (CRO) that is completely dedicated to clinical trials in ophthalmology in Western Europe (Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, United Kingdom), Eastern Europe (Bulgaria, Czech Republic, Poland, Roumania), North Africa (Tunisia, Morocco), Asia (Israel, India, Saudi Arabia, Turkey,) and North America (USA, Canada).

The new entity dedicated to clinical trials in ophthalmology will be known as Iris Pharma. The company works in five complementary areas for a global drug development of eye product: bioanalytical testing, ocular drug development, non-GLP pre-clinical formulation, pre-clinical services, clinical trials and strategic consulting.